MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE TO SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could bring relief to millions with severe eczema
Disease control Not yet recruitingThis study tests an experimental oral medication called LW402 for adults with moderate-to-severe atopic dermatitis (eczema). About 480 participants will receive either the drug or a placebo to see if it safely improves skin symptoms like redness and itching. The main goal is to m…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE3 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:49 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called CMS-D001 in 160 adults with moderate to severe atopic dermatitis (eczema) who haven't responded well to standard creams. The goal is to see if the drug can reduce skin redness, itching, and rash by at least 75%. Participants will recei…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New eczema drug shows promise in early trial
Disease control Not yet recruitingThis study tests a new medicine called AK139 for people with moderate-to-severe eczema (atopic dermatitis). About 168 adults will receive either AK139 or a placebo to see if it safely improves skin symptoms like itching and rash. The goal is to find a better treatment option for …
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
New pill could soothe severe eczema – trial underway
Symptom relief Not yet recruitingThis study tests an experimental capsule called QLS12010 in 160 adults with moderate-to-severe atopic dermatitis (eczema). Half will get the drug, half a placebo, and researchers will check if it reduces eczema severity and itching over 16 weeks. The goal is to see if the drug is…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 08:50 UTC